CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CXCR4-Targeted Macrophage-Derived Biomimetic Hybrid Vesicle Nanoplatform for Enhanced Cancer Therapy through Codelivery of Manganese and Doxorubicin

Published:2024-03-27 Issue:14 Volume:16 Page:17129-17144
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Jang Yeonwoo¹^ORCID,Cho Young Seok²³^ORCID,Kim April²,Zhou Xingwu²^ORCID,Kim Yujin²³^ORCID,Wan Ziye²,Moon James J.²³⁴^ORCID,Park Hansoo¹^ORCID

Affiliation:

1. School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea

2. Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109, United States

3. Biointerfaces Institute, University of Michigan, Ann Arbor, Michigan 48109, United States

4. Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States

Funder

National Cancer Institute

National Institute of Diabetes and Digestive and Kidney Diseases

Ministry of Science and ICT, South Korea

National Institute of Allergy and Infectious Diseases

National Institute of Biomedical Imaging and Bioengineering

National Science Foundation

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.3c18569

Reference50 articles.

1. A Review of Cancer Immunotherapy: From the Past, to the Present, to the Future

2. Delivery technologies for cancer immunotherapy

3. Cancer immunotherapy: harnessing the immune system to battle cancer

4. Combination therapy in combating cancer

5. The Interplay of Immunotherapy and Chemotherapy: Harnessing Potential Synergies

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor‑associated macrophages activated in the tumor environment of hepatocellular carcinoma: Characterization and treatment (Review);International Journal of Oncology;2024-09-05

2. Advances in Nanomaterials for Immunotherapeutic Improvement of Cancer Chemotherapy;Small;2024-05-21

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3